TRPA1 and Alzheimer disease: Melatonin may be an effective option in the treatment and prophylaxis of AD by reducing cytosolic Ca2+ concentration, apoptosis and intracellular ROS through TRPA1 channels (Ozsimsek and Ovey, 2022).